In Brief: FoxMeyer
Executive Summary
FoxMeyer: Dissatisfaction with joint ownership with Phar-Mor CEO Robert Haft of Hamilton Morgan, a limited liability company whose sole investment is a 31% stake in Phar-Mor, prompts FoxMeyer to invoke buy/sell option. Should Haft buy FoxMeyer's 69.8% stake in Hamilton Morgan, the wholesaler would realize cash proceeds of $26.6 mil.; should Haft sell his stake, his proceeds would total $7.2 mil...